Neurocrine Biosciences, Inc. (NASDAQ:NBIX) CEO Sells $432,227.20 in Stock theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Neurocrine Biosciences (NASDAQ:NBIX) Price Target Lowered to $140.00 at Citigroup themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) CEO Kevin Charles Gorman sold 3,040 shares of Neurocrine Biosciences stock in a transaction on Tuesday, February 6th. The stock was sold at an average price of $142.18, for a total value of $432,227.20. Following the transaction, the chief executive officer now directly owns 504,919 shares of […]
Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report) announced its quarterly earnings results on Wednesday. The company reported $1.44 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.13 by $0.31, Briefing.com reports. Neurocrine Biosciences had a return on equity of 12.85% and a net margin of 13.23%. The business had revenue of […]
Neurocrine Biosciences (NASDAQ:NBIX) Releases Quarterly Earnings Results, Beats Expectations By $0.31 EPS kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.